Company Filing History:
Years Active: 2011-2012
Title: Innovations of Zhongshun Yang in Immunosuppressive Therapies
Introduction
Zhongshun Yang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of artemisinin derivatives. With a total of 2 patents, his work focuses on innovative solutions for treating autoimmune diseases and improving transplant outcomes.
Latest Patents
Yang's latest patents include groundbreaking research on water-soluble artemisinin derivatives. These patents detail their preparation methods, pharmaceutical compositions, and potential uses. The artemisinin derivatives have been shown to possess immunosuppressive activities, making them valuable in treating diseases caused by hyperfunction of human immunity, such as lupus erythematosus, rheumatoid arthritis, and multiple sclerosis. Additionally, these compounds may help inhibit graft rejection following cell or organ transplantation.
Another notable patent involves the preparation methods and uses of artemisinin derivatives, which can be formulated into long-term dosage forms like tablets and pellets. This innovation enhances the safety and efficacy of immunosuppressive therapies, providing a wider range of applications in medical treatments.
Career Highlights
Zhongshun Yang is affiliated with the Chinese Academy of Sciences, where he conducts his research and development. His work has garnered attention for its potential impact on immunology and transplant medicine.
Collaborations
Yang collaborates with esteemed colleagues, including Ying Nan Li and Jianping Zuo, to further advance his research and innovations in the field.
Conclusion
Zhongshun Yang's contributions to the development of artemisinin derivatives represent a significant advancement in immunosuppressive therapies. His innovative work holds promise for improving treatment options for autoimmune diseases and enhancing transplant success rates.